Follow Up Pathway (Severe COVID-19 pneumonia) – ICST

Follow Up Pathway (Severe COVID-19 pneumonia)

Those individuals who have presented with severe COVID-19 pneumonia, including those who have been managed on an intensive care unit or required CPAP or high concentrations of oxygen therapy on a COVID-19 ward, or those who experienced complications of COVID-19 pneumonia during their admission, should be followed up according to the British Thoracic Society pathway (linked below).

The BTS guideline describes a structured approach to follow-up of patients with severe COVID-19 following their discharge from hospital. This includes a holistic review at 4-6 weeks assessing for clinical improvement, breathlessness, oxygen requirements, rehabilitation and psychological needs. A 12 week face to face review should include a repeat CXR to check for radiological resolution. In some patients further imaging and physiological tests will be required to screen for late complications of COVID-19.

The recommendation of the BTS guidelines is to assess patients in a dedicated post COVID-19 clinic, allowing data collection and research into the potential complications of COVID-19.

Follow Up Pathway (Severe COVID-19 pneumonia)

Those individuals who have presented with severe COVID-19 pneumonia, including those who have been managed on an intensive care unit or required CPAP or high concentrations of oxygen therapy on a COVID-19 ward, or those who experienced complications of COVID-19 pneumonia during their admission, should be followed up according to the British Thoracic Society pathway (linked below).

The BTS guideline describes a structured approach to follow-up of patients with severe COVID-19 following their discharge from hospital. This includes a holistic review at 4-6 weeks assessing for clinical improvement, breathlessness, oxygen requirements, rehabilitation and psychological needs. A 12 week face to face review should include a repeat CXR to check for radiological resolution. In some patients further imaging and physiological tests will be required to screen for late complications of COVID-19.

The recommendation of the BTS guidelines is to assess patients in a dedicated post COVID-19 clinic, allowing data collection and research into the potential complications of COVID-19.

Follow Up of Patients with COVID-19 pneumonia

Follow Up Pathway (Mild to Moderate COVID-19 pneumonia)

Mark as Understood

Resources

BTS Guidance on Respiratory Follow Up of Patients with a Clinico-Radiological Diagnosis of COVID-19 Pneumonia

This guidance outlines British Thoracic Society (BTS) recommended follow up of patients with a clinico-radiological diagnosis of COVID-19 pneumonia.

Template letter 1: Offer follow up Post-COVID19 CXR

This template letter has been provided by British Thoracic Society (BTS) to offer follow up post-COVID19 Chest xray.

Template letter 2: Follow up post COVID19 pneumonia CXR cleared Discharge

This template letter has been provided by British Thoracic Society (BTS) to discharge the patient from further COVID19 follow up.

Template letter 3: Follow up post COVID19 need PFT and OPD or telephone assessment

This template letter has been provided by British Thoracic Society (BTS) to offer Pulmonary Function Testing (PFT) or telephone assessment.

© Institute of Clinical Science and Technology (ICST) 2020

Support: admin@clinicalscience.org.uk